Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,437 | 13,155 | 16,221 | 22,317 | 11,644 |
| Receivables | 142 | 202 | 241 | 264 | 196 |
| TOTAL | $9,297 | $14,297 | $17,600 | $23,111 | $12,668 |
| Non-Current Assets | |||||
| PPE Net | 102 | 118 | 127 | 143 | 174 |
| TOTAL | $102 | $118 | $127 | $143 | $174 |
| Total Assets | $9,399 | $14,415 | $17,727 | $23,254 | $12,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,361 | 5,775 | 5,374 | 5,092 | 5,071 |
| Other current liabilities | N/A | N/A | N/A | N/A | 3 |
| TOTAL | $2,388 | $5,801 | $5,398 | $5,116 | $5,097 |
| Non-Current Liabilities | |||||
| TOTAL | $71 | $77 | $81 | $92 | $98 |
| Total Liabilities | $2,459 | $5,878 | $5,479 | $5,207 | $5,196 |
| Shareholders' Equity | |||||
| Common Shares | 136,007 | 129,807 | 124,889 | 130,879 | 113,345 |
| Retained earnings | -149,466 | -141,633 | -130,604 | -130,820 | -125,856 |
| TOTAL | $6,940 | $8,537 | $12,248 | $18,047 | $7,646 |
| Total Liabilities And Equity | $9,399 | $14,415 | $17,727 | $23,254 | $12,842 |